Free Trial
NASDAQ:AFJKR

Aimei Health Technology (AFJKR) Stock Price, News & Analysis

$0.22 0.00 (0.00%)
As of 05/21/2025

About Aimei Health Technology Stock (NASDAQ:AFJKR)

Key Stats

Today's Range
$0.22
$0.22
50-Day Range
$0.22
$0.36
52-Week Range
$0.10
$0.39
Volume
1,800 shs
Average Volume
57,695 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

Receive AFJKR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aimei Health Technology and its competitors with MarketBeat's FREE daily newsletter.

AFJKR Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

AFJKR Stock Analysis - Frequently Asked Questions

Aimei Health Technology's stock was trading at $0.18 at the start of the year. Since then, AFJKR stock has increased by 22.9% and is now trading at $0.2212.
View the best growth stocks for 2025 here
.

Shares of AFJKR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
-
Sub-Industry
Trading
Current Symbol
NASDAQ:AFJKR
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
N/A
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:AFJKR) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners